공지사항

Acute Myeloid Leukemia Injury

Cancer that begins in blood stem cells and then spreads rapidly to bone-marrow and blood. The cancer causes too many immature white blood cells to be produced, thereby crowding out healthy cells. Leukemia cells may also expand to other parts of the human body including the liver and spleen. They can also cause tumor in the central nervous system (brain and spinal cord).

The treatment is based on the subtype of AML and if it has spread. It may include chemotherapy, radiation therapy or medications that treat other types of cancer.

Signs and symptoms

The blood-forming cells which make up the bone marrow and blood (leukemia cells) get out of control. They become abnormal white blood cell that never becomes healthy red blood cells and platelets. The cancerous cells obstruct the normal blood-forming cells, causing issues with the immune system and other parts of the body.

The symptoms may appear suddenly, often within a couple of weeks or days. They can be accompanied by fatigue, fever, easy bleeding or Acute Myeloid Leukemia Injury bruising and vomiting. Biopsies of the bone marrow and blood tests can reveal an abnormal white cell count.

If the cancer spreads to the brain, it can cause headaches, seizures or vision and balance problems. It could also affect your heart and lungs. It is often difficult to tell if the leukemia is located in the brain or the chest, which is why doctors use a test called an lumbar puncture. It is a procedure to take a sample of cerebrospinal liquid (CSF) for analysis.

A Lumbar puncture procedure that involves inserting a needle inside the lower back. It is typically done by an anesthesiologist, but patients can opt to have it done by a nurse or doctor. CSF tests can tell whether the leukemia is located in the spine, or has metastasized to the brain, and other areas of the body.

Diagnosis

Leukemia occurs when a bone marrow cells has changes (mutations) in its DNA. DNA informs cells how to grow and when to die. When a bone marrow cell has DNA mutations, it can't make normal white blood cells and other kinds of healthy blood cells. The abnormal cells obstruct healthy cells and hinder the body from fighting infection. Children with acute myelogenous leukemia have a high number of immature blood cells referred to as myeloblasts and they're lacking healthy red blood cells, also known as platelets (PLATE-lits).

Leukemia is diagnosed by physical examination and health history. The doctor will examine the patient to look for signs of cancer, such as fever or a lump appearing on the skin. The doctor will also inquire with the patient about any past ailments and treatments.

Blood tests can reveal how well the organs function and the levels of certain chemicals present in the blood. A blood sample can be examined for the presence of normal white blood cells and red blood cells and platelets. A special test could be used to check for bones marrow chromosomes.

Other tests may reveal complications triggered by the leukemia, or from its treatment. These can include changes in skin color or a tumor in the chest or with the spinal cord or brain.

Treatment

In this form of leukemia, mature blood cells build up and block healthy blood cells. It is a problem with hematopoietic stems cells, which are the blood-forming cells in bone marrow (the soft, acute Myeloid leukemia injury spongy substance in the long bones). Hematopoietic cells mature into red blood, white blood and platelets. The term "acute myeloid leukemia lawsuit settlement", which means that the disease is growing rapidly indicates that the illness is in its early stages. This type of leukemia can be also referred to as acute myeloid leukemia myelogenous or acute myeloid leukemia railroad injury myeloblastic or acute myeloid leukemia cancer settlement granulocytic.

Doctors diagnose leukemia based upon symptoms and results from certain tests. Imaging tests such as X scans, CT scans and MRI are used to determine whether leukemia has spread from the brain to the chest. Other laboratory tests such as flow-cytometry can help doctors determine the type and subtypes of leukemia. This is important, because treatment depends on the type.

AML patients are at a high-risk of developing complications. These complications can be caused by the leukemia itself, or its treatments, such as chemotherapy and radiation therapy. These include recurrent infections or anemia (low number of red blood cells), bleeding problems easy bruising and low numbers (neutropenia and thrombocytopenia) of blood-forming cell. Certain people experience the appearance of tiny flat spots on the skin or inside the mouth. They may also suffer from swollen lymph nodes or spleens (hepatomegaly or splenomegaly). Some individuals may suffer from mood swings, or changes in their thinking or behavior due to the progress of the disease, or chemotherapy.

The following is a list with preventions.

AML develops when blood cells called stem cells in the bone marrow (the soft, spongy substance within bones) produce too many immature white blood cells. These cells aren't normal and don't fight infections as they should. They also crowd healthy blood-producing cells. This could lead to a lack of different types healthy blood cells.

The risk of AML increases with age. Smoking, radiation exposure, and previous chemotherapy treatments, and certain genetic mutations like an all-trans retinoic acid (ATRA) (Alkeran) or enasidenib, may also increase the risk.

Doctors treat AML by utilizing medicines that target specific proteins involved in the growth of cancerous cells. This includes medications such as azacitidine (Vidaza) decitabine (Dacogen) and midostaurin (Rydapt). Radiation therapy employs high-energy x rays or other particles that destroy cancerous cells. Once a patient is in remission, doctors can prescribe drugs to stop cancer from recurring. This is known as recurrence. This includes nilotinib (Imatinib), and avastin (Rydapt). Patients can also be treated with the latest drugs that are currently being evaluated in clinical studies. A bone marrow transplant with healthy hematopoietic stem cells is another method to treat AML. These are donated by a donor or taken from the patient's bone marrow.